guest ::
| Home > Publications Database > Enzymatic Activity of HPGD in Treg Cells Suppresses Tconv Cells to Maintain Adipose Tissue Homeostasis and Prevent Metabolic Dysfunction. > print |
| Home > Publications Database > Enzymatic Activity of HPGD in Treg Cells Suppresses Tconv Cells to Maintain Adipose Tissue Homeostasis and Prevent Metabolic Dysfunction. > print |
| 001 | 140709 | ||
| 005 | 20240321220848.0 | ||
| 024 | 7 | _ | |a 10.1016/j.immuni.2019.03.014 |2 doi |
| 024 | 7 | _ | |a pmid:31027998 |2 pmid |
| 024 | 7 | _ | |a 1074-7613 |2 ISSN |
| 024 | 7 | _ | |a 1097-4180 |2 ISSN |
| 024 | 7 | _ | |a altmetric:59402713 |2 altmetric |
| 037 | _ | _ | |a DZNE-2020-07031 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Schmidleithner, Lisa |0 P:(DE-2719)2812337 |b 0 |e First author |u dzne |
| 245 | _ | _ | |a Enzymatic Activity of HPGD in Treg Cells Suppresses Tconv Cells to Maintain Adipose Tissue Homeostasis and Prevent Metabolic Dysfunction. |
| 260 | _ | _ | |a New York, NY |c 2019 |b Elsevier |
| 264 | _ | 1 | |3 print |2 Crossref |b Elsevier BV |c 2019-05-01 |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1709893056_26558 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Regulatory T cells (Treg cells) are important for preventing autoimmunity and maintaining tissue homeostasis, but whether Treg cells can adopt tissue- or immune-context-specific suppressive mechanisms is unclear. Here, we found that the enzyme hydroxyprostaglandin dehydrogenase (HPGD), which catabolizes prostaglandin E2 (PGE2) into the metabolite 15-keto PGE2, was highly expressed in Treg cells, particularly those in visceral adipose tissue (VAT). Nuclear receptor peroxisome proliferator-activated receptor-γ (PPARγ)-induced HPGD expression in VAT Treg cells, and consequential Treg-cell-mediated generation of 15-keto PGE2 suppressed conventional T cell activation and proliferation. Conditional deletion of Hpgd in mouse Treg cells resulted in the accumulation of functionally impaired Treg cells specifically in VAT, causing local inflammation and systemic insulin resistance. Consistent with this mechanism, humans with type 2 diabetes showed decreased HPGD expression in Treg cells. These data indicate that HPGD-mediated suppression is a tissue- and context-dependent suppressive mechanism used by Treg cells to maintain adipose tissue homeostasis. |
| 536 | _ | _ | |a 341 - Molecular Signaling (POF3-341) |0 G:(DE-HGF)POF3-341 |c POF3-341 |f POF III |x 0 |
| 536 | _ | _ | |a 342 - Disease Mechanisms and Model Systems (POF3-342) |0 G:(DE-HGF)POF3-342 |c POF3-342 |f POF III |x 1 |
| 542 | _ | _ | |i 2019-05-01 |2 Crossref |u https://www.elsevier.com/tdm/userlicense/1.0/ |
| 542 | _ | _ | |i 2020-05-21 |2 Crossref |u http://www.elsevier.com/open-access/userlicense/1.0/ |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 650 | _ | 7 | |a STAT5 Transcription Factor |2 NLM Chemicals |
| 650 | _ | 7 | |a 15-ketoprostaglandin E2 |0 2S0F1FTK13 |2 NLM Chemicals |
| 650 | _ | 7 | |a Hydroxyprostaglandin Dehydrogenases |0 EC 1.1.1.- |2 NLM Chemicals |
| 650 | _ | 7 | |a Dinoprostone |0 K7Q1JQR04M |2 NLM Chemicals |
| 650 | _ | 2 | |a 3T3 Cells |2 MeSH |
| 650 | _ | 2 | |a Animals |2 MeSH |
| 650 | _ | 2 | |a Cell Line |2 MeSH |
| 650 | _ | 2 | |a Diabetes Mellitus, Type 2: metabolism |2 MeSH |
| 650 | _ | 2 | |a Dinoprostone: analogs & derivatives |2 MeSH |
| 650 | _ | 2 | |a Dinoprostone: metabolism |2 MeSH |
| 650 | _ | 2 | |a HEK293 Cells |2 MeSH |
| 650 | _ | 2 | |a Homeostasis: immunology |2 MeSH |
| 650 | _ | 2 | |a Humans |2 MeSH |
| 650 | _ | 2 | |a Hydroxyprostaglandin Dehydrogenases: genetics |2 MeSH |
| 650 | _ | 2 | |a Hydroxyprostaglandin Dehydrogenases: metabolism |2 MeSH |
| 650 | _ | 2 | |a Insulin Resistance: genetics |2 MeSH |
| 650 | _ | 2 | |a Intra-Abdominal Fat: cytology |2 MeSH |
| 650 | _ | 2 | |a Intra-Abdominal Fat: immunology |2 MeSH |
| 650 | _ | 2 | |a Jurkat Cells |2 MeSH |
| 650 | _ | 2 | |a Lymphocyte Activation: immunology |2 MeSH |
| 650 | _ | 2 | |a Male |2 MeSH |
| 650 | _ | 2 | |a Mice |2 MeSH |
| 650 | _ | 2 | |a Mice, Knockout |2 MeSH |
| 650 | _ | 2 | |a STAT5 Transcription Factor: metabolism |2 MeSH |
| 650 | _ | 2 | |a T-Lymphocytes, Regulatory: enzymology |2 MeSH |
| 650 | _ | 2 | |a T-Lymphocytes, Regulatory: immunology |2 MeSH |
| 700 | 1 | _ | |a Thabet, Yasser |b 1 |
| 700 | 1 | _ | |a Schönfeld, Eva |b 2 |
| 700 | 1 | _ | |a Köhne, Maren |0 P:(DE-2719)2812698 |b 3 |u dzne |
| 700 | 1 | _ | |a Sommer, Daniel |b 4 |
| 700 | 1 | _ | |a Abdullah, Zeinab |b 5 |
| 700 | 1 | _ | |a Sadlon, Timothy |b 6 |
| 700 | 1 | _ | |a Osei-Sarpong, Collins |0 P:(DE-2719)2813660 |b 7 |u dzne |
| 700 | 1 | _ | |a Subbaramaiah, Kotha |b 8 |
| 700 | 1 | _ | |a Copperi, Francesca |b 9 |
| 700 | 1 | _ | |a Haendler, Kristian |b 10 |
| 700 | 1 | _ | |a Varga, Tamas |0 P:(DE-2719)2812488 |b 11 |u dzne |
| 700 | 1 | _ | |a Schanz, Oliver |b 12 |
| 700 | 1 | _ | |a Bourry, Svenja |0 P:(DE-2719)2811740 |b 13 |u dzne |
| 700 | 1 | _ | |a Bassler, Kevin |b 14 |
| 700 | 1 | _ | |a Krebs, Wolfgang |b 15 |
| 700 | 1 | _ | |a Peters, Annika E |b 16 |
| 700 | 1 | _ | |a Baumgart, Ann-Kathrin |b 17 |
| 700 | 1 | _ | |a Schneeweiss, Maria |b 18 |
| 700 | 1 | _ | |a Klee, Kathrin |b 19 |
| 700 | 1 | _ | |a Schmidt, Susanne V |b 20 |
| 700 | 1 | _ | |a Nüssing, Simone |b 21 |
| 700 | 1 | _ | |a Sander, Jil |b 22 |
| 700 | 1 | _ | |a Ohkura, Naganari |b 23 |
| 700 | 1 | _ | |a Waha, Andreas |b 24 |
| 700 | 1 | _ | |a Sparwasser, Tim |b 25 |
| 700 | 1 | _ | |a Wunderlich, F Thomas |b 26 |
| 700 | 1 | _ | |a Förster, Irmgard |b 27 |
| 700 | 1 | _ | |a Ulas, Thomas |0 P:(DE-2719)9000845 |b 28 |u dzne |
| 700 | 1 | _ | |a Weighardt, Heike |b 29 |
| 700 | 1 | _ | |a Sakaguchi, Shimon |b 30 |
| 700 | 1 | _ | |a Pfeifer, Alexander |b 31 |
| 700 | 1 | _ | |a Blüher, Matthias |b 32 |
| 700 | 1 | _ | |a Dannenberg, Andrew J |b 33 |
| 700 | 1 | _ | |a Ferreirós, Nerea |b 34 |
| 700 | 1 | _ | |a Muglia, Louis J |b 35 |
| 700 | 1 | _ | |a Wickenhauser, Claudia |b 36 |
| 700 | 1 | _ | |a Barry, Simon C |b 37 |
| 700 | 1 | _ | |a Schultze, Joachim L |0 P:(DE-2719)2811660 |b 38 |u dzne |
| 700 | 1 | _ | |a Beyer, Marc |0 P:(DE-2719)2812219 |b 39 |e Last author |u dzne |
| 773 | 1 | 8 | |a 10.1016/j.immuni.2019.03.014 |b : Elsevier BV, 2019-05-01 |n 5 |p 1232-1248.e14 |3 journal-article |2 Crossref |t Immunity |v 50 |y 2019 |x 1074-7613 |
| 773 | _ | _ | |a 10.1016/j.immuni.2019.03.014 |g Vol. 50, no. 5, p. 1232 - 1248.e14 |0 PERI:(DE-600)2001966-X |n 5 |q 50:5<1232 - 1248.e14 |p 1232-1248.e14 |t Immunity |v 50 |y 2019 |x 1074-7613 |
| 856 | 4 | _ | |u https://pub.dzne.de/record/140709/files/DZNE-2020-07031_Restricted.pdf |
| 856 | 4 | _ | |u https://pub.dzne.de/record/140709/files/DZNE-2020-07031_Restricted.pdf?subformat=pdfa |x pdfa |
| 909 | C | O | |p VDB |o oai:pub.dzne.de:140709 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 0 |6 P:(DE-2719)2812337 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 3 |6 P:(DE-2719)2812698 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 7 |6 P:(DE-2719)2813660 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 11 |6 P:(DE-2719)2812488 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 13 |6 P:(DE-2719)2811740 |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 28 |6 P:(DE-2719)9000845 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 38 |6 P:(DE-2719)2811660 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 39 |6 P:(DE-2719)2812219 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Erkrankungen des Nervensystems |1 G:(DE-HGF)POF3-340 |0 G:(DE-HGF)POF3-341 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Molecular Signaling |x 0 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Erkrankungen des Nervensystems |1 G:(DE-HGF)POF3-340 |0 G:(DE-HGF)POF3-342 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Disease Mechanisms and Model Systems |x 1 |
| 914 | 1 | _ | |y 2019 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2022-11-12 |w ger |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b IMMUNITY : 2021 |d 2022-11-12 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2022-11-12 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2022-11-12 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2022-11-12 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2022-11-12 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2022-11-12 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2022-11-12 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2022-11-12 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2022-11-12 |
| 915 | _ | _ | |a IF >= 40 |0 StatID:(DE-HGF)9940 |2 StatID |b IMMUNITY : 2021 |d 2022-11-12 |
| 920 | 1 | _ | |0 I:(DE-2719)1013035 |k AG Beyer |l Immunogenomics and Neurodegeneration |x 0 |
| 920 | 1 | _ | |0 I:(DE-2719)1013012 |k AG Alamoudi |l Cryo-electron microscopy and tomography |x 1 |
| 920 | 1 | _ | |0 I:(DE-2719)1013031 |k Schultze - PRECISE |l Platform for Single Cell Genomics and Epigenomics |x 2 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-2719)1013035 |
| 980 | _ | _ | |a I:(DE-2719)1013012 |
| 980 | _ | _ | |a I:(DE-2719)1013031 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|